Newsletter | September 20, 2012

09.20.12 -- Prefilled Syringes: The Next "Big Thing"

Prefilled Syringes: The Next "Big Thing" By Cliff Mintz, Ph.D.

		Prefilled syringes are rapidly replacing the vial-and-syringe format due to the growing use of biologics and biotech drugs coupled with patients who self-administer treatments. Read more.

Outsourcing Articles

A Diversified Portfolio Of CROs Might Improve Results
By Kate Hammeke, director of marketing intelligence, Nice Insight
Whether an outsourcing relationship is tactical or with a preferred vendor or strategic partner, each of these different types of outsourcing relationships has its merits. Read more.

Comparing China's And India's Pharmaceutical Manufacturing
By Jim Zhang, Ph.D., JZMed, Inc.
In many aspects, China and India are very similar, but both countries have different advantages in the pharmaceutical manufacturing industry. Read more.

Featured Multimedia

	Introduction To Stick Packaging Video Looking for an innovative way to package your product? Ropack recognizes that the unique design of stick-pack offers benefits both to its own customers as well as consumers.

Featured Outsourcing Applications


	Too Much, Too Soon? Phase-Appropriate Is Better Phase-Appropriate Drug Development: Another small way we make a big difference; and just one more way we demonstrate the ABC difference. Read more.


	Critical Considerations For HPAPI Manufacturing At A CMO High potency API (HPAPI) compound manufacture is growing every year, primarily due to the ever increasing potency and cytotoxicity of oncology drugs. Read more.


	Project Management In API Development And Manufacturing The development and manufacture of an active pharmaceutical ingredient (API) is a crucial component of the pharmaceutical supply chain. Read more.

Outsourcing News


Twitter	LinkedIn

Free Bioresearch Online Newsletter